Zobrazeno 1 - 6
of 6
pro vyhledávání: '"E C Shamblen"'
Autor:
Kenneth C. Lasseter, Ralph H. Raymond, Maria R. Marino, E. C. Shamblen, Kathleen M. Langenbacher, Neville F. Ford, F. Beierle
Publikováno v:
Clinical Drug Investigation. 14:383-391
The primary objective of this study was to assess the effect of hydrochlorothiazide on the pharmacokinetics of irbesartan in patients with mild-to-moderate hypertension. In addition, this study compared the pharmacodynamic and tolerability profiles o
Effects of aluminum hydroxide and calcium carbonate antacids on the bioavailability of ciprofloxacin
Publikováno v:
Antimicrobial Agents and Chemotherapy. 36:830-832
This study was designed to determine the effects of an aluminum hydroxide antacid and a calcium carbonate antacid on the bioavailability of ciprofloxacin (Cipro). Cipro (750 mg) was administered orally to 12 healthy volunteers in a three-way randomiz
Autor:
E C Shamblen, S J Justice, Gregory A. Winchell, C M Chavez, Daniel Z. Wang, K. C. Lasseter, David L. Ebel, A. Van Hecken, I De Lepeleire, M L Constanzer, Jules I. Schwartz, Barry J. Gertz, P. J. De Schepper
Publikováno v:
The Journal of clinical endocrinology and metabolism. 81(8)
Two isozymes (types 1 and 2) of 5 alpha-reductase (5 alpha R; EC 1.3.99.5), with differential tissue distribution, have been identified in humans. These enzymes catalyze the reduction of testosterone (T) to dihydrotestosterone (DHT). The contribution
Autor:
Ole Vesterqvist, Kathleen M. Langenbacher, E. C. Shamblen, Kenneth C. Lasseter, Maria R. Marino, Neville F. Ford
Publikováno v:
American Journal of Hypertension. 10:121A
Autor:
K C, Lasseter, E C, Shamblen, A A, Murdoch, D E, Burkholder, G J, Krol, R J, Taylor, S K, Vanov
Publikováno v:
Journal of cardiovascular pharmacology. 6
As a calcium antagonist, nitrendipine will be used in the treatment of various diseases in patients with hepatic insufficiency, and it is important to know if they require modified dosing schedules. In this study, six patients with biopsy-confirmed c
Autor:
L I, Harrison, R C, Smallridge, K C, Lasseter, M B, Goldlust, E C, Shamblen, V W, Gam, S F, Chang, D C, Kvam
Publikováno v:
The American review of respiratory disease. 134(2)
The inhalation of atropine sulfate was investigated in a randomized, 4-period, rising-dose study. Atropine sulfate 2, 4, and 6 mg by inhalation, and atropine free base 1.67 mg (equivalent to 2.0 mg atropine sulfate) by intramuscular (IM) injection we